Abstract:Translational medicine is known as biomedicine models with purpose of finding solutions for clinical challenges. The clustered regularly interspaced short palindromic repeats associated protein 9 (CRISPR‐Cas9) system makes impressive strides therein through gene knockout, knock‐in, activation, interference, base editing, and sequence detection, and continues to revolutionize the development of translational medicine. Translational medicine aims to improve human health by exploring potential treatment methods developed during basic scientific research and applying them to the treatment of patients in clinical settings. The advanced perceptions of gene functions have remarkably revolutionized clinical treatment strategies for target agents. However, the progress in gene editing therapy has been hindered due to the severe off‐target effects and limited editing sites. Fortunately, the development in the clustered regularly interspaced short palindromic repeats associated protein 9 (CRISPR‐Cas9) system has renewed hope for gene therapy field. The CRISPR‐Cas9 system can fulfill various simple or complex purposes, including gene knockout, knock‐in, activation, interference, base editing, and sequence detection. Accordingly, the CRISPR‐Cas9 system is adaptable to translational medicine, which calls for the alteration of genomic sequences. This review aims to present the latest CRISPR‐Cas9 technology achievements and prospect to translational medicine advances. The principle and characterization of the CRISPR‐Cas9 system are firstly introduced. The authors then focus on recent pre‐clinical and clinical research directions, including the construction of disease models, disease‐related gene screening and regulation, and disease treatment and diagnosis for multiple refractory diseases. Finally, some clinical challenges including off‐target effects, in vivo vectors, and ethical problems, and future perspective are also discussed.

CRISPR-Cas System: The Current and Emerging Translational Landscape

Development and application of CRISPR/Cas9 technologies in genomic editing.

CRISPR/Cas9‐mediated genome editing: From basic research to translational medicine

Progress and Perspective of CRISPR‐Cas9 Technology in Translational Medicine

CRISPR-Cas Systems: Overview, Innovations and Applications in Human Disease Research and Gene Therapy

Applications and challenges of CRISPR-Cas gene-editing to disease treatment in clinics

CRISPR/Cas9-mediated genome editing: from basic research to gene therapy

CRISPR-Cas9: A Preclinical and Clinical Perspective for the Treatment of Human Diseases

The Applications of the CRISPR/Cas9 Gene-Editing System in Treating Human Diseases

CRISPR technologies for genome, epigenome and transcriptome editing

Progress and Application of CRISPR/Cas Technology in Biological and Biomedical Investigation.

Current trends of clinical trials involving CRISPR/Cas systems

Recent Therapeutic Gene Editing Applications to Genetic Disorders

CRISPR/Cas System in Human Genetic Diseases

Precision in Action: The Role of Clustered Regularly Interspaced Short Palindromic Repeats/Cas in Gene Therapies

CRISPR/Cas systems usher in a new era of disease treatment and diagnosis

The Potential of CRISPR/Cas9 Gene Editing as a Treatment Strategy for Inherited Diseases

CRISPR/Cas9 Technology: Applications and Human Disease Modeling

Principles of CRISPR-Cas9 technology: Advancements in genome editing and emerging trends in drug delivery

Next-generation CRISPR technology for genome, epigenome and mitochondrial editing

CRISPR/Cas9 therapeutics: progress and prospects